Rodger Novak's Insider Trades & SAST Disclosures

Rodger Novak's most recent trade in CRISPR Therapeutics AG was a trade of 25,000 Common Shares done at an average price of $165 . Disclosure was reported to the exchange on June 30, 2021.

Share

Note

This is a custom search result for pattern Rodger Novak.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
CRISPR Therapeutics AG	Rodger Novak	Director, President	Sale of securities on an exchange or to another person at price $ 165.00 per share.	30 Jun 2021	25,000	573,007 (0%)	0%	165	4,125,000	Common Shares
CRISPR Therapeutics AG	Rodger Novak	Director, President	Sale of securities on an exchange or to another person at price $ 156.55 per share.	28 Jun 2021	25,000	598,007 (0%)	0%	156.6	3,913,750	Common Shares
CRISPR Therapeutics AG	Rodger Novak	Director, President	Sale of securities on an exchange or to another person at price $ 128.76 per share.	21 Jun 2021	12,630	630,356 (1%)	0%	128.8	1,626,239	Common Shares
CRISPR Therapeutics AG	Rodger Novak	Director, President	Sale of securities on an exchange or to another person at price $ 129.46 per share.	21 Jun 2021	7,299	623,057 (1%)	0%	129.5	944,929	Common Shares
CRISPR Therapeutics AG	Rodger Novak	Director, President	Sale of securities on an exchange or to another person at price $ 127.71 per share.	21 Jun 2021	2,969	642,986 (1%)	0%	127.7	379,171	Common Shares
CRISPR Therapeutics AG	Rodger Novak	Director, President	Sale of securities on an exchange or to another person at price $ 125.58 per share.	21 Jun 2021	1,171	646,836 (1%)	0%	125.6	147,054	Common Shares
CRISPR Therapeutics AG	Rodger Novak	Director, President	Sale of securities on an exchange or to another person at price $ 126.62 per share.	21 Jun 2021	881	645,955 (1%)	0%	126.6	111,552	Common Shares
CRISPR Therapeutics AG	Rodger Novak	Director, President	Sale of securities on an exchange or to another person at price $ 130.28 per share.	21 Jun 2021	50	623,007 (1%)	0%	130.3	6,514	Common Shares

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades